New Long-Term Zeposia (Ozanimod) Data Demonstrate Durable Efficacy and Consistent Safety in Relapsing Forms of Multiple Sclerosis
新的長期Zeposia(Ozanimod)數據表明在多發性硬化的複發性型中具有持久的療效和一致的安全性
New Long-Term Zeposia (Ozanimod) Data Demonstrate Durable Efficacy and Consistent Safety in Relapsing Forms of Multiple Sclerosis
新的長期Zeposia(Ozanimod)數據表明在多發性硬化的複發性型中具有持久的療效和一致的安全性
譯文內容由第三人軟體翻譯。